| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |